Evaxion establishes new AI-derived precision cancer vaccine concept
Go back to Evaxion establishes new AI-derived precision cancer vaccine concept| (NASDAQ: EVAX) | Delayed: 3.04 +0.06 (2.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.98 | 52 Week High | $ | |||
| Open | $3.00 | 52 Week Low | $ | |||
| Day High | $3.19 | P/E | N/A | |||
| Day Low | $2.99 | EPS | $ | |||
| Volume | 29,076 | |||||

